Single Domain Antibody And scFv Affinity Improvement
TypeName: Business Offer
Category:
Offer Date:2019/05/25
Country: United States
Summary: Creative Biolabs has built a novel single domain antibody affinity improvement platform, using our exclusive HIAF-ProNanoTM affinity improvement technology. HIAF-ProNano™ can improve the target binding affinity of single domain antibodies and scFvs substantially by engaging of protein nanocages without changing any of the physico-chemical characteristics of single domain antibodies and scFvs. Great success has been made in improving the binding affinity of single domain antibody and scFv using our HIAF-ProNano™ platform. https://www.creative-biolabs.com/Nanobody-affinity-improvement.html
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
